3D-Printed Artificial Airway Fixation Device for Obese Patients
Study on 3D-Printed Artificial Airway Fixation Device for Obese Patients: A Randomized Controlled Trial
1 other identifier
interventional
66
1 country
1
Brief Summary
This study is looking for a better way to secure breathing tubes for obese patients who need them. For patients with obesity, a short neck and extra tissue can make it difficult to keep a breathing tube in the correct position. When a tube moves, it can cause serious problems. Researchers want to compare a new, personalized breathing tube holder with the standard methods currently used. Participants in this study will be randomly assigned to one of two groups: The Intervention Group will use a new tube holder made with a 3D printer. This holder is custom-designed to fit the specific shape of the patient's face. The Control Group will use the standard methods to secure the breathing tube, such as a conventional holder or medical tape. Researchers will check things like how well the tube stays in place, the condition of the patient's skin around the mouth, and the comfort of the patient. The goal is to see if the new 3D-printed device is safer, more secure, and more comfortable for obese patients with a breathing tube. The study will include 66 adult patients who are obese and require a breathing tube.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 9, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 16, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 16, 2025
CompletedFirst Submitted
Initial submission to the registry
September 12, 2025
CompletedFirst Posted
Study publicly available on registry
January 16, 2026
CompletedJanuary 16, 2026
January 1, 2026
10 months
September 12, 2025
January 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Endotracheal Tube Displacement or Dislodgement Grade
The stability of the endotracheal tube is assessed using a 5-point grading scale. Grade 1: No displacement. Grade 2: Mild displacement (change of \<1 cm). Grade 3: Moderate displacement (change of 1-2 cm). Grade 4: Severe displacement (change of \>2 cm). Grade 5: Unplanned extubation (tube is completely dislodged).
From intubation through extubation, an average of 7 days.
Local Skin Integrity
The contact area was inspected daily and recorded for skin irritation or allergic reaction, categorized as "Yes" or "No".
Daily from intubation through extubation, up to 14 days.
Airway Management Safety Indicators
Safety indicators are measured during each nursing procedure (oral care and replacement of the fixation device), including: ①Irritative Cough Duration: The duration (in seconds) of a patient's continuous coughing or choking is recorded. ②Heart Rate and SpO₂ Fluctuation: Heart rate (beats/minute) and peripheral oxygen saturation (SpO₂) are monitored and recorded before and after each procedure to assess changes.
Average of measurements taken during each oral care procedure from intubation through extubation (an average of 7 days)
Study Arms (2)
3D-Printed Personalized Fixation Device
EXPERIMENTALThis arm uses a personalized artificial airway fixation device for obese patients, developed with 3D printing technology, to secure the endotracheal tube.
Conventional Fixation Methods
ACTIVE COMPARATORFor Orotracheally Intubated Patients: The standard method involves passing the endotracheal tube through a conventional fixer, tightening the screw cap, and fastening a strap around the neck.
Interventions
This study uses a personalized artificial airway fixation device for obese patients, developed with 3D printing technology, to secure the endotracheal tube.For Orotracheally Intubated Patients: A fixation device is personalized based on the patient's head and facial contour data. The device is integrally printed with medical-grade silicone-like soft and hard resin, featuring a soft skin-friendly inner side, a rigid movable dual-track structural design, and antimicrobial material on the inner wall.
For Orotracheally Intubated Patients: The standard method involves passing the endotracheal tube through a conventional fixer, tightening the screw cap, and fastening a strap around the neck.
Eligibility Criteria
You may qualify if:
- Age 18-75 years.
- Meets indications for endotracheal intubation.
- Body Mass Index (BMI) ≥28 kg/m².
- Intact skin around the mouth, cheeks, and neck without lesions before endotracheal intubation.
- Estimated intubation time \>12 hours.
- The patient or their family understands and voluntarily participates in this study, and signs the informed consent form.
You may not qualify if:
- Patients with a history of psychiatric diagnosis.
- Patients with laryngeal injury.
- Patients with oral diseases or facial skin damage.
- Patients who have undergone intubation more than once during the current hospitalization.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tang-Du Hospitallead
Study Sites (1)
Tangdu Hospital
Xi'an, Shaanxi, 710038, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 12, 2025
First Posted
January 16, 2026
Study Start
July 9, 2024
Primary Completion
May 16, 2025
Study Completion
May 16, 2025
Last Updated
January 16, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- The de-identified individual participant data will be publicly shared within 6 months after the first publication of the main research results. The data will remain available for a minimum of 5 years.
- Access Criteria
- Data will be made available for use by the scientific research community. Access will be provided through a data application and sharing mechanism via the ResMan platform. All shared data will be de-identified to protect participant privacy .
All de-identified individual participant data collected during the study will be shared.